Skip to content

Cholinergic network modulation in disinhibited eating behaviour

Cholinergic network modulation in disinhibited eating behaviour - IFB-FluPET/MR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00010927
Enrollment
60
Registered
2016-08-04
Start date
2017-06-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disinhibited eating behaviour E66

Interventions

Group 1: Investigation of 40 non-smoking obese volunteers with BMI >35 kg/m2 of whom N=20 have high disinhibition and N=20 have low disinhibition regarding their eating behaviour with simultaneous PE

Sponsors

Universitätsklinikum Leipzig AöR Klinik und Poliklinik für Nuklearmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: - obese: BMI > 35 kg/m²; healthy control: BMI < 25 kg/m2 - age between 18-65 years; ? / ? - non-smoking

Exclusion criteria

Exclusion criteria: - current or past neurological or psychiatric disease, (i.e. depression and anxiety) - neurosurgical interventions - structural tissue lesions in the braín (e.g. stroke, trauma) - use of anorexic medication or other interventions for weight loss in the past 6 months - prescription medication (i.e. neurotropic drugs); - past or present history of alcohol misuse or the use of illegal drugs (ensured by means of psychological tests and urine Screening) - known cognitive deficits or speech impairment - simultaneous participation in any other interventional clinical study according to the German Medicinal Products Act (MPA) - pregnancy and breast-feeding (or other contraindications for the use of radiotracers) - MRI contraindications such as ferro-magnetism, or claustrophobia

Design outcomes

Primary

MeasureTime frame
The primary outcome of our study is the quantitatively determined availavbility of the central a4ß2*-nAChR (binding potential and distribution volume ratio) in the human brain.

Secondary

MeasureTime frame
MRI-(resting state; task-related fMRI data, especially markers of connectivity), behavioural (impulsivity, cognition, social development) as well as hormonal (leptin, ghrelin, insulin) Parameters and their correlation with a4ß2*-nAChR binding potential and distribution volume ratio.

Countries

Germany

Contacts

Public ContactSwen Hesse

Univesitätsklinikum Leipzig Klinik und Poliklinik für Nuklearmedizin

swen.hesse@medizin.uni-leipzig.de+49 341/ 97 18081

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026